Spain-based Catalyxx, a developer of bio-based chemicals, has secured a

€20 million grant from the European Union through RenewChem, a flagship project

selected by the Circular Bio-based Europe Joint Undertaking (CBE JU). The

funding will support the construction of Catalyxx's first commercial bio-based

chemicals plant in Europe, marking the company's transition from technology